by Cryostem | Aug 31, 2020
Check Abstract A103 on the #EBMT20Virtual e-poster area Background : Even if Chimeric Antigen Receptor (CAR)-T cells therapies are a promising way to treat relapsed/refractory hematologic cancers, authorities face major issues regarding their economic impact, the... 
by Cryostem | Aug 24, 2020
Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge – AUGUST 20, 2020 “Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD”.... 
by Cryostem | Apr 6, 2020
Robert, E., Fontenille, C., Dalle, J.-H., de Latour, R.P. and Calmels, B., 2020. “CRYOSTEM Biobank: A National Prospective, Standardized Collection to Better Characterize Allogeneic Hematopoietic Stem Cell Transplantation Complications”. Open Journal of Bioresources,... 
by Cryostem | Mar 2, 2020
CRYOSTEM is launching its annual call for projects on the thematic of HSCT complications. Access to the unique European biological resources collection of transplanted patients enabling you to validate preliminary results on larger cohorts or to support the discovery... 
by Cryostem | Jan 21, 2020
CRYOSTEM teams up with CALYM (a Carnot institute devoted to Lymphoma) to develop a new biological resources collection (blood, stools and urines) of patients suffering from lymphoma and treated by CAR-T cells. This collection of high clinical and biological value will... 